Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP12 | P39900 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.40 |
| ▸ | CTSA | P10619 | 3/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | HMOX2 | P30519 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.37 |
| ▸ | PLOD3 | O60568 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL170301 | 0.88 | SLC6A2 (0.55) | MMP12MMP13FFAR1LMNASLC6A2 | |
| Hydrochloric Acid SCHEMBL128794 | 0.86 | SLC6A2 (0.53) | MMP12MMP13FFAR1LMNASLC6A2 | |
| SCHEMBL5705693 | 0.83 | FFAR1 (0.50) | FFAR1LMNACTSAEPHX2HPGD | |
| SCHEMBL7215779 | 0.78 | CYP19A1 (0.43) | LMNASLC6A2SLC6A4SLC6A3NAPRT | |
| SCHEMBL3526103 | 0.78 | MMP12 (0.47) | MMP12MMP13SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4449939 | 0.78 | MMP12 (0.47) | MMP12MMP13SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1677568 | 0.76 | FFAR1 (0.54) | MMP12MMP13FFAR1SLC6A2SLC6A4 | |
| SCHEMBL2999878 | 0.76 | GRM8 (0.43) | MMP12MMP13SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5720968 | 0.76 | GRM8 (0.43) | MMP12MMP13SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3908031 | 0.76 | L3MBTL1 (0.56) | MMP12MMP13LMNASLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6617474-B2 | Reacting olefinically unsaturated compound with carbon monoxide and hydrogen in presence of polar phase comprising: a non-aqueous ionic liquid comprising quaternary ammonium and/or a quaternary phosphonium compound and catalyst; adding solvent | INSTITUT FRANCAIS DU PETROLE (FR) | 2003-09-09 | — | — | US | disclosed |
| US-20020099243-A1 | Process for the hydroformylation of olefinically unsaturated compounds in a non-aqueous ionic solvent | INSTITUT FRANCAIS DU PETROLE (FR) | 2002-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020099243-A1 | Process for the hydroformylation of olefinically unsaturated compounds in a non-aqueous ionic solvent | NUDT1, PHOSPHO1, SRSF6 | MMP12 4216/4885MMP13 4364/4885FFAR1 2075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.